HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan.

AbstractCONTEXT:
Some patients with elevated serum thyroglobulin (Tg) but a negative diagnostic whole body scan (WBS) after initial therapy for differentiated thyroid carcinoma may benefit from empirical radioactive iodine (RAI) therapy. However, previous studies enrolled patients with negative diagnostic WBS, regardless of neck ultrasonography (USG) and/or (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET), which have become the preferred diagnostic procedures in such patients.
OBJECTIVE:
The aim of this study was to evaluate the usefulness of empirical RAI therapy in patients with elevated stimulated Tg level and negative USG/FDG-PET findings after initial therapy for papillary thyroid carcinoma (PTC).
DESIGN:
This comparative study enrolled 39 patients with elevated stimulated Tg, negative diagnostic WBS, and negative USG/FDG-PET 1 yr after initial treatment. Empirical RAI therapy was performed in 14 patients (treatment group), whereas 25 patients were followed up without therapy (control group).
RESULTS:
There was no significant between-group difference in basal clinicopathological parameters. None of the 14 patients in the treatment group showed iodine uptake on posttreatment WBS. Five of 14 patients (36%) in the treatment group and eight of 25 (32%) in the control group had recurrence during the median 37 months of follow-up (P = 0.99). Changes in serum stimulated Tg concentrations did not differ between the two groups.
CONCLUSION:
Empirical RAI therapy and posttreatment WBS were not useful diagnostically or therapeutically in patients with positive serum stimulated Tg if such patients had negative USG and negative FDG-PET findings after initial treatment of PTC.
AuthorsWon Gu Kim, Jin-Sook Ryu, Eui Young Kim, Jeong Hyun Lee, Jung Hwan Baek, Jong Ho Yoon, Suck Joon Hong, Eun Sook Kim, Tae Yong Kim, Won Bae Kim, Young Kee Shong
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 95 Issue 3 Pg. 1169-73 (Mar 2010) ISSN: 1945-7197 [Electronic] United States
PMID20080852 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Iodine Radioisotopes
  • Fluorodeoxyglucose F18
  • Thyroglobulin
Topics
  • Adolescent
  • Adult
  • Aged
  • Carcinoma, Papillary (blood, diagnostic imaging, radiotherapy)
  • Child
  • Dose-Response Relationship, Radiation
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Iodine Radioisotopes (therapeutic use)
  • Male
  • Middle Aged
  • Radionuclide Imaging
  • Recurrence
  • Statistics, Nonparametric
  • Thyroglobulin (blood)
  • Thyroid Neoplasms (blood, diagnostic imaging, radiotherapy)
  • Treatment Outcome
  • Ultrasonography
  • Whole Body Imaging

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: